,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['enhertu', '$azn']
db-04 reviewer p lorusso's conclusions for #asco22 and enhertu... and another big round of applause... $azn and $dskny got to be pretty pleased right now. 
Pharma and biotech reporter, found a home at Evaluate Vantage.